Nobel Biocare acquires Versah, expanding its regeneratives and implant solutions portfolio
Zurich, Switzerland - February 9, 2026 - Nobel Biocare, part of the Envista family of brands, announced the acquisition of Versah®, a leading innovator in dental osteotomy and bone densification solutions. By bringing Versah’s Densah® Burs and pioneering Osseodensification technique into its portfolio – supported by the regenerative leadership of Osteogenics – Nobel Biocare strengthens its ability to support clinicians with solutions that help shorten “time to teeth” by facilitating immediate implant placement and provisionalization in more cases. Their solutions also support regenerative procedures, such as sinus elevation and ridge expansion. This addition aligns with Nobel Biocare’s long‑standing commitment to advancing science‑driven implant solutions.
Founded in 2014 and based in Jackson, Michigan, Versah has transformed implant site preparation through its patented Densah Bur technology, the original innovation that has reshaped implant site preparation. Unlike traditional drills that remove bone, Densah Burs compact and autograft bone outward, helping create an osteotomy environment that is designed to support primary stability and widen treatment possibilities. Supported by more than a decade of biomechanical, histological, and clinical research and adopted by thousands of clinicians worldwide, this recognized innovative technology brings a differentiated, evidence-based advancement to Nobel Biocare’s regenerative and implant portfolio.
“We are thrilled to welcome Versah to Nobel Biocare,” said Stefan Nilsson, President of Nobel Biocare. “Their Densah Bur technology is grounded in significant scientific validation and represents an important advancement in how clinicians approach implant site preparation. Integrating this level of innovation reinforces our commitment to delivering evidence‑based solutions that support predictable, high‑quality patient care.”
Dr. Salah Huwais, founder of Versah, added: “Joining Nobel Biocare marks an exciting new chapter for Versah. With Nobel Biocare's global reach and strong clinical heritage, we can bring the benefits of Osseodensification to even more dental professionals and their patients. I’m looking forward to this next phase of innovation and growth together.”
The acquisition underscores Nobel Biocare's commitment to expanding its regenerative and implant solutions portfolio, delivering advanced clinical outcomes, and serving clinicians through innovation, quality, and digital excellence.
ABOUT NOBEL BIOCARE
Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company's portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including Nobel Biocare N1™, NobelActive®, NobelParallel™, and the All-on-4® treatment concept), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (Procera™), prefabricated prosthetics, and a wide variety of regenerative solutions (creos™). Products are supported by a single digital platform for imaging, diagnostics, and treatment planning (DTX Studio™ suite), and guided and navigated surgery (NobelGuide® and X-Guide®). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland, and production takes place at sites located in the United States and Sweden. Products and services are available in over 50 countries through subsidiaries and distributors. Nobel Biocare is part the Envista family, one of the largest global dental products companies with more than 30 trusted dental brands. For more information, please visit https://www.nobelbiocare.com.
ABOUT VERSAH
Versah® is a dental solutions company founded in 2014 and based in Jackson, Michigan. The company develops patented instrumentation for implant site preparation and is recognized for introducing the Osseodensification concept to the dental community. Versah’s products are supported by biomechanical, histological, and clinical research and are used by clinicians worldwide.
ABOUT ENVISTA HOLDINGS CORPORATION
Envista is a global leader in the dental industry, uniting more than 30 trusted brands—including DEXIS, Kerr, Nobel Biocare, and Ormco—under one mission: partnering with dental professionals to improve patients’ lives. With a heritage of category-defining innovation, our brands have shaped modern dentistry: Nobel Biocare was founded by the inventor of titanium implants, Ormco is a pioneer in both traditional and digital orthodontics, DEXIS has long been at the forefront of 2D, 3D and intraoral imaging, and Kerr has supported clinicians for over 135 years. Our high-performing culture is underpinned by our CIRCLe Values and the Envista Business System. Guided by these, we deliver a comprehensive portfolio of technologies, consumables, and services that empower clinicians to provide confident, efficient care—today and for the future. Learn more at http://envistaco.com.
